- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07227974
Empower EI: Comparing Early Intervention Approaches to Improve Communication in Toddlers With Developmental Delays
This study is testing three ways to deliver Early Intervention (EI) services for toddlers with developmental disabilities (DD).
Children enrolled in EI speech therapy will receive one of three approaches:
- Therapist Delivered EI: For 28 weeks, the child's speech therapist will work directly with the child to support their communication.
- Caregiver Coaching EI: For 28 weeks, the child's speech therapist will coach the caregiver on how to support their child's communication.
- Combined EI Approach + Parent-Led Education Program: For 14 weeks, the caregiver will take part in a parent-led education program while the speech therapist works directly with the child to support their communication. During the next 14 weeks, the speech therapist will coach the caregiver on how to support their child's communication.
The goal of this study is to identify which approaches are most effective so that all families can benefit fully from EI services.
Study Overview
Status
Conditions
Detailed Description
High-quality Early Intervention (EI) during the first three years of life, a period of heightened neuroplasticity, is critical to improving outcomes for children with developmental disabilities (DD). There are two EI approaches that may be effective for supporting child communication and improving family outcomes: 1) caregiver coaching, in which the EI therapist teaches the caregiver strategies to help their child's communication, and 2) caregiver psychoeducation, in which a peer mentor teaches the caregiver about skills and resources that are helpful in supporting their child and family.
The aim of the current clinical trial is to determine which EI approaches are most effective, for which families, and why they are effective. This clinical trial also aims to investigate how therapists are delivering the interventions and to characterize the acceptability and feasibility of these interventions for use in real-world settings.
A total of 1,269 toddlers (approximately equal numbers of Black, Latine, and white children) will be enrolled across community-based EI sites. Families will be directly recruited from participating EI therapists' existing caseloads. Caregiver-child dyads will be randomly assigned to one of three groups:
- Therapist Delivered EI: For 28 weeks, the child's speech therapist will work directly with the child to support their communication.
- Caregiver Coaching EI: For 28 weeks, the child's speech therapist will coach the caregiver on how to support their child's communication.
- Combined EI Approach + Parents Taking Action: For 14 weeks, the caregiver will take part in a parent-led education program (Parents Taking Action) while the speech therapist works directly with the child to support their communication. During the next 14 weeks, the speech therapist will coach the caregiver on how to support their child's communication.
Outcomes will assess both caregiver and child domains, including caregiver use of responsive strategies, caregiver capacity to support the child's needs, and child social communication. The study will also examine moderators (e.g., race) and mediators (e.g., caregiver use of responsive strategies) to identify for whom and why each approach is most effective.
A process evaluation will assess implementation fidelity (quality, dosage, adaptations) and explore how fidelity influences effectiveness outcomes. Feasibility, acceptability, and appropriateness of each approach will be evaluated through surveys and interviews with caregivers and EI therapists.
This study is among the first large-scale comparative effectiveness trials of early intervention approaches conducted in real-world EI settings. Findings will inform EI practices and guide caregivers, therapists, and policymakers in selecting interventions that best meet the needs and preferences of diverse families.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Laura Sudec, Masters
- Phone Number: 1-847-491-3183
- Email: laura.sudec@northwestern.edu
Study Locations
-
-
Illinois
-
Evanston, Illinois, United States, 60201
- Recruiting
- Northwestern University
-
Principal Investigator:
- Megan Roberts, PhD
-
Contact:
- Laura Sudec, Masters
- Email: laura.sudec@northwestern.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Child Inclusion Criteria:
- At least 12 months old
- At least 7 months of Early Intervention (EI) service eligibility remaining
- Enrolled in the Illinois EI system and is new to the speech-language pathologist's (SLP's) caseload (i.e., no prior EI speech-language therapy experience with the SLP)
- Plans to receive one hour of speech-language therapy per week in the home or in a private space outside of the home
Child Exclusion Criteria:
- Exposed to a language other than English or Spanish more than 10% of the time
Caregiver Inclusion Criteria:
- The child's parent, legal guardian, or other family member
- Self-identifies as Black, Latine (Hispanic), or white
- Available to participate in weekly EI sessions and study assessments.
Caregiver Exclusion Criteria
- Younger than 18 years old at enrollment
- Uses a language other than English or Spanish during their interactions with the child more than 10% of the time
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Therapist-Delivered Early Intervention Approach
For 28 weeks, this arm will receive the therapist-delivered early intervention approach.
|
The therapist-delivered early intervention approach will occur during the child's weekly, hour-long early intervention (EI) sessions.
During the sessions, the child's EI speech-language pathologist (SLP) will use responsive strategies directly with the child.
Responsive strategies focus on noticing the child's communication and responding with language related to their focus of attention.
The SLP will not coach the caregiver during the sessions.
|
|
Experimental: Caregiver Coaching Early Intervention Approach
For 28 weeks, this arm will receive the caregiver coaching early intervention approach.
|
The caregiver-coaching early intervention approach will occur during the child's weekly, hour-long early intervention (EI) sessions.
During the sessions, the child's EI speech-language pathologist (SLP) will coach the caregiver to use responsive strategies with their child.
Responsive strategies focus on noticing the child's communication and responding with language related to their focus of attention.
|
|
Experimental: Combined Early Intervention Approach + Parents Taking Action
For the first 14 weeks, this arm will receive the therapist-delivered early intervention as well as Parents Taking Action.
For the following 14 weeks, this arm will receive the caregiver coaching early intervention approach.
|
The therapist-delivered early intervention approach will occur during the child's weekly, hour-long early intervention (EI) sessions.
During the sessions, the child's EI speech-language pathologist (SLP) will use responsive strategies directly with the child.
Responsive strategies focus on noticing the child's communication and responding with language related to their focus of attention.
The SLP will not coach the caregiver during the sessions.
The caregiver-coaching early intervention approach will occur during the child's weekly, hour-long early intervention (EI) sessions.
During the sessions, the child's EI speech-language pathologist (SLP) will coach the caregiver to use responsive strategies with their child.
Responsive strategies focus on noticing the child's communication and responding with language related to their focus of attention.
Parents Taking Action (PTA) will be delivered during weekly, one-hour virtual sessions with the caregiver, separate from the child's early intervention (EI) sessions.
PTA is a psychoeducation program implemented by a peer mentor (i.e., a culturally-matched caregiver of a child with a developmental disability).
During the sessions, the peer mentor will provide information and guidance on a range of topics (e.g., child development, early intervention systems, special education rights/resources, and advocacy) following a structured curriculum.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Family Outcomes Survey - Revised
Time Frame: Week 14, Week 28
|
The Family Outcomes Survey-Revised is a 24-item informant-report questionnaire that assesses caregivers' understanding, confidence, and ability to support their child's needs.
The Family Outcomes Total Score (Min = 24, Max = 120) reflects the caregiver's capacity to support their child's needs, with higher scores indicating greater capacity.
|
Week 14, Week 28
|
|
Communication and Symbolic Behavior Scales - Developmental Profile (CSBS-DP)
Time Frame: Week 28
|
The Communication and Symbolic Behavior Scales - Developmental Profile (CSBS-DP) is a structured, norm-referenced, observational measure of child communication.
The assessment is scored for 20 items across 7 domains (i.e., Emotion and Eye Gaze, Communication, Gestures, Sounds, Words, Understanding, Object Use).
The weighted raw scores for each of the 7 domains are grouped into 3 clusters (social, speech, and symbolic) and combined into a total raw score (min = 0; max = 113).
Higher scores indicate better skills.
|
Week 28
|
|
Responsive Strategy Use (RSU) Rating Scale
Time Frame: Week 14, Week 28
|
The Responsive Strategy Use (RSU) Rating Scale will be used to measure caregivers' use of responsive strategies during a naturalistic, caregiver-child interaction.
Items on the RSU Rating Scale are rated on a 5-point Likert Scale (1 = Rarely/Never, 5 = Consistently) and averaged to yield the RSU Total Score (Min = 1, Max = 5), with higher scores reflecting a higher frequency of responsive strategy use.
|
Week 14, Week 28
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Session Attendance
Time Frame: Week 1 to Week 28
|
Session attendance will be documented in weekly session logs completed by interventionists and summarized as the percentage of planned intervention sessions attended by each family (Min = 0%, Max = 100%).
|
Week 1 to Week 28
|
|
Intervention Fidelity Checklist
Time Frame: Week 1 to Week 28
|
The Intervention Fidelity Checklist is a rating scale assessing adherence to the intervention protocol.
Items on the checklist correspond to the core elements of the respective intervention protocol and are scored based on specific behavioral criteria.
The Intervention Fidelity Checklist will be scored on a randomly selected 20% of intervention sessions per participant.
Scores will be averaged across sessions to yield an average intervention quality score (Min = 0, Max = 100), with higher scores indicating higher intervention quality.
|
Week 1 to Week 28
|
|
Framework for Reporting Adaptations and Modifications (FRAME)
Time Frame: Week 1 to Week 28
|
The Framework for Reporting Adaptations and Modifications (FRAME) will be used to document intervention adaptations.
Adaptations will be documented through intervention session logs and direct observations of intervention sessions.
These data will yield the total number of adaptations (Min = 0, Max = NA).
|
Week 1 to Week 28
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Early Intervention Program Satisfaction Scale
Time Frame: Week 14, Week 28
|
An adapted version of the Early Intervention Program Satisfaction Scale, a caregiver-report questionnaire, will be used to assess caregiver satisfaction.
This survey includes 6 items rated on a 5-point Likert (1 = Very Dissatisfied, 5 = Very Satisfied).
The Total Score (Min = 6, Max = 30) reflects caregivers' overall satisfaction with the intervention, with higher scores representing greater satisfaction.
|
Week 14, Week 28
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Megan Roberts, PhD, Northwestern University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Nervous System Diseases
- Mental Disorders
- Neurobehavioral Manifestations
- Neurodevelopmental Disorders
- Communication Disorders
- Language Disorders
- Pathological Conditions, Signs and Symptoms
- Behavior
- Signs and Symptoms
- Developmental Disabilities
- Language Development Disorders
- Communication
Other Study ID Numbers
- BPS-2024C1-38924
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
De-identified individual participant data (IPD) that underlie the results reported in any publication arising from this trial will be made publicly available via the Dryad repository. The shared dataset will include all variables necessary to reproduce the published findings, including treatment assignment, participant demographics, baseline characteristics, and outcome measures. All data will be de-identified in accordance with HIPAA standards and institutional policies to protect participant confidentiality.
Data will be uploaded to Dryad after publication of the primary results, and will be freely accessible to qualified researchers without restriction. A corresponding DOI will be provided in publications to facilitate data access and citation.
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Developmental Delays
-
Children's Hospital of PhiladelphiaCompletedDevelopmental DelaysUnited States
-
Children's Hospital of PhiladelphiaCenters for Disease Control and PreventionCompletedDevelopmental DelaysUnited States
-
Taipei Medical UniversityUnknown
-
JeeHyun SuhNational IT Industry Promotion Agency, Republic of KoreaCompleted
-
Taipei Medical UniversityCompletedDevelopmental DelaysTaiwan
-
Ru-Lan HsiehCompleted
-
Oregon Social Learning CenterNational Institute of Mental Health (NIMH)CompletedDevelopmental Delays | School ReadinessUnited States
-
Taipei Medical UniversityUnknown
-
Hacettepe UniversityCompletedMusculoskeletal Diseases | Genetic Disease | Metabolic Disease | Delays DevelopmentalTurkey
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingNeurodevelopment | Neurodevelopment Outcome | Neurodevelpmental Delays
Clinical Trials on Therapist-Delivered Early Intervention Approach
-
Karolinska InstitutetRegion StockholmRecruitingPost Traumatic Stress DisorderSweden
-
Ohio State UniversityCompletedAutism Spectrum DisorderUnited States
-
Gazi UniversityCompletedInfant, Premature, DiseasesTurkey
-
Gazi UniversityCompletedCerebral Palsy | Preterm | Sensory DisordersTurkey
-
Virginia Commonwealth UniversityNational Institute on Drug Abuse (NIDA)CompletedSubstance Use DisorderUnited States
-
Region StockholmKarolinska InstitutetCompleted
-
Karolinska InstitutetRegion Stockholm; Barn-och ungdomspsykiatrin (BUP), StockholmCompleted
-
Stockholm UniversityCompletedSocial Anxiety DisorderSweden
-
Karolinska InstitutetRegion StockholmCompleted
-
Linkoeping UniversityCompleted